345834 <common-name>(5z)-1-(2,5-dichlorophenyl)-5-[(4-fluorophenyl)methylidene]-3-(4-morpholin-4-ylphenyl)-2-sulfanylidene-1,3-diazinane-4,6-dione</common-name> <description>(5z)-1-(2,5-dichlorophenyl)-5-[(4-fluorophenyl)methylidene]-3-(4-morpholin-4-ylphenyl)-2-sulfanylidene-1,3-diazinane-4,6-dione is a chemical compound with the formula C27H20Cl2FN3O3S. With an average molecular weight of 556.40 g/mol, (5z)-1-(2,5-dichlorophenyl)-5-[(4-fluorophenyl)methylidene]-3-(4-morpholin-4-ylphenyl)-2-sulfanylidene-1,3-diazinane-4,6-dione is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>6449418</pubchem-id> <chemical-formula>C27H20Cl2FN3O3S</chemical-formula> <weight>556.4</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T08:50:43Z</created-at> <updated-at type="dateTime">2026-08-31T08:50:43Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1COCCN1C2=CC=C(C=C2)N3C(=O)C(=CC4=CC=C(C=C4)F)C(=O)N(C3=S)C5=C(C=CC(=C5)Cl)Cl</moldb-smiles> <moldb-formula>C27H20Cl2FN3O3S</moldb-formula> <moldb-inchi>InChI=1S/C27H20Cl2FN3O3S/c28-18-3-10-23(29)24(16-18)33-26(35)22(15-17-1-4-19(30)5-2-17)25(34)32(27(33)37)21-8-6-20(7-9-21)31-11-13-36-14-12-31/h1-10,15-16H,11-14H2/b22-15-</moldb-inchi> <moldb-inchikey>PEQKZZVDCMDEDQ-JCMHNJIXSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">555.0586462</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM341727</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(5z)-1-(2,5-dichlorophenyl)-5-[(4-fluorophenyl)methylidene]-3-(4-morpholin-4-ylphenyl)-2-sulfanylidene-1,3-diazinane-4,6-dione</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Oxazinanes</klass> <subklass>Morpholines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0296188</sync-id> <structure-inchikey>PEQKZZVDCMDEDQ-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>c0000000000000002040000000000000000400000000000080004000000000004000000020000000000002000000000140000000000000000000000000001000000000400000000000000000000020802000010210000000000000000000000000000080000800020000110000000000020100020000000000000002100020000000000000000000008000000000000080000000000010000000000000000100008000000000000000080000042000000040000000008000000000000000000000000004000000000000000000020012000000040000000200000400000000000040000000000040000000000000800000000000000000000000004000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKQAAAIABBgBgAAAAAgIGAGAAAAAC AggAIAAAAAIGAGAAAAACAgYAYAAAAAICBwAoAAAAAwMGQCgAAAADBAZAaAAA AAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBwAoAAAA AwMGACgAAAADBAgAKAAAAAMCBgAoAAAAAwQGAGgAAAADAwEGQCgAAAADBAZA aAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBCQAg AAAAAQYAKAAAAAMECAAoAAAAAwIHACgAAAADAwYAKAAAAAMEEAAoAAAAAwIG QCgAAAADBAZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgA AAADAwERACAAAAABEQAgAAAAAQsAAQABAgACAwADBAAEBQAFBiAGB2gMBwho DAgJaAwJCmgMCgtoDAkMIAwNIA0OKAINDyAPECgCEBEgERJoDBITaAwTFGgM FBVoDBUWaAwUFwAPGCAYGSgCGBogGhsgGxwoAhodIB0eaAweH2gMHyBoDCAh aAwhImgMISMAHiQABQAACwZoDBsMIBYRaAwiHWgMQgUAAAAGAAUEAwIBBgcI CQoLBgYNDxgaGwwGEhMUFRYRBh4fICEiHRcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:44:45Z</structure-indexed-at> </compound>